Patents by Inventor Mahmoud Ameri

Mahmoud Ameri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200000712
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 2, 2020
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao, Peter C. Schmidt
  • Publication number: 20190070103
    Abstract: Applicant hereby submits a substitute abstract that is double spaced.
    Type: Application
    Filed: August 23, 2018
    Publication date: March 7, 2019
    Inventors: Mahmoud Ameri, Donald Kellerman, Yi Ao
  • Publication number: 20180153799
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: January 29, 2018
    Publication date: June 7, 2018
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Publication number: 20180153798
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: October 9, 2017
    Publication date: June 7, 2018
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Patent number: 9918932
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: March 20, 2018
    Assignee: Zosano Pharma Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Patent number: 9782344
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: October 10, 2017
    Assignee: ZP OPCO, INC.
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Publication number: 20170239174
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: February 21, 2017
    Publication date: August 24, 2017
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Publication number: 20170135951
    Abstract: Compositions of and methods for formulating and delivering biologically active agent formulations having enhanced physical stability, and wherein deterioration from the presence of oxygen and/or water is minimized and/or controlled, to yield a stable formulation. The compositions of and methods for formulating and delivering biologically active agents of the present invention further facilitate their incorporation into a biocompatible coating which can be employed to coat a stratum-corneum piercing microprojection, or a plurality of stratum-corneum piercing microprojections of a delivery device, for delivery of the biocompatible coating through the skin of a subject, thus providing an effective means of delivering the biologically active agents.
    Type: Application
    Filed: January 30, 2017
    Publication date: May 18, 2017
    Inventors: Mahmoud Ameri, Michel J.N. Cormier, Scott Sellers, Yuh-Fun Maa
  • Patent number: 9573717
    Abstract: Compositions of and methods for formulating and delivering biologically active agent formulations having enhanced physical stability, and wherein deterioration from the presence of oxygen and/or water is minimized and/or controlled, to yield a stable formulation. The compositions of and methods for formulating and delivering biologically active agents of the present invention further facilitate their incorporation into a biocompatible coating which can be employed to coat a stratum-corneum piercing microprojection, or a plurality of stratum-corneum piercing microprojections of a delivery device, for delivery of the biocompatible coating through the skin of a subject, thus providing an effective means of delivering the biologically active agents.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: February 21, 2017
    Assignee: ALZA CORPORATION
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Scott Sellers, Yuh-Fun Maa
  • Patent number: 9295714
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: March 29, 2016
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Yuh-Fun Maa, Peter E. Daddona, Marika Kamberi
  • Publication number: 20160051467
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: November 2, 2015
    Publication date: February 25, 2016
    Inventors: Mahmoud AMERI, Peter E. DADDONA, Yi AO
  • Patent number: 9173924
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: November 3, 2015
    Assignee: ZP OPCO, INC.
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Publication number: 20150057605
    Abstract: There is provided glucagon formulations suitable for preparing coatings on microneedle patches for the transdermal delivery of glucagon. The coated patches may be used for the treatment of low blood sugar in diabetic patients. Also provided are glucagon loaded patches, methods for their preparation, and methods of their use.
    Type: Application
    Filed: August 22, 2014
    Publication date: February 26, 2015
    Inventors: Mahmoud Ameri, Peter E. Daddona, Yi Ao
  • Patent number: 8920817
    Abstract: The invention provides for a formulation for coating one or more microprojections which reduces or minimizes the loss of counterions from the coating in order to achieve a pH-stabilized formulation.
    Type: Grant
    Filed: August 24, 2009
    Date of Patent: December 30, 2014
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Wei-Qi Lin, Michel J. N. Cormier, Yuh-Fun Maa
  • Publication number: 20140260096
    Abstract: Compositions of and methods for formulating and delivering biologically active agent formulations having enhanced physical stability, and wherein deterioration from the presence of oxygen and/or water is minimized and/or controlled, to yield a stable formulation. The compositions of and methods for formulating and delivering biologically active agents of the present invention further facilitate their incorporation into a biocompatible coating which can be employed to coat a stratum-corneum piercing microprojection, or a plurality of stratum-corneum piercing microprojections of a delivery device, for delivery of the biocompatible coating through the skin of a subject, thus providing an effective means of delivering the biologically active agents.
    Type: Application
    Filed: January 21, 2014
    Publication date: September 18, 2014
    Applicant: ALZA CORPORATION
    Inventors: Mahmoud Ameri, Michel J.N. Cormier, Scott Sellers, Yuh-Fun Maa
  • Patent number: 8633159
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: January 21, 2014
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Yuh-Fun Maa, Marika Kamberi, Peter E. Daddona
  • Patent number: 8632801
    Abstract: Compositions of and methods for formulating and delivering biologically active agent formulations having enhanced physical stability, and wherein deterioration from the presence of oxygen and/or water is minimized and/or controlled, to yield a stable formulation. The compositions of and methods for formulating and delivering biologically active agents of the present invention further facilitate their incorporation into a biocompatible coating which can be employed to coat a stratum-corneum piercing microprojection, or a plurality of stratum-corneum piercing microprojections of a delivery device, for delivery of the biocompatible coating through the skin of a subject, thus providing an effective means of delivering the biologically active agents.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: January 21, 2014
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Scott Sellers, Yuh-Fun Maa
  • Patent number: 8361022
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: January 29, 2013
    Assignee: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J. N. Cormier, Yuh-Fun Maa, Peter E. Daddona, Marika Kamberl
  • Publication number: 20100160895
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Application
    Filed: March 2, 2010
    Publication date: June 24, 2010
    Applicant: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J.N. Cormier, Yuh-Fun Maa, Marika Kamberi, Peter E. Daddona
  • Publication number: 20100152649
    Abstract: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.
    Type: Application
    Filed: July 1, 2009
    Publication date: June 17, 2010
    Applicant: Alza Corporation
    Inventors: Mahmoud Ameri, Michel J.N. Cormier, Yuh-Fun Maa, Peter E. Daddona, Marika Kamberl